Prostheses List Reforms – PwC Report on Reforms to the Prostheses List Part B – May 2023

Closed 6 Oct 2023

Opened 23 Aug 2023

Contact

Prescribed List Reforms Taskforce

prescribedlist.reforms@Health.gov.au

Feedback updated 6 May 2025

We asked

We asked you to provide feedback on PricewaterhouseCoopers' (PwC) report and recommendations to modernise Part B.

We asked you if you agreed with the recommendations. We also invited you to suggest alternative options for each recommendation.

You said

We received 20 stakeholder submissions.

You raised specific concerns about the need to improve and modernise Part B application process. These included:

  • restructuring the classification system for human tissue and organ products (products) to improve consistency and clarity
  • streamlining the application process for listing products
  • improving stakeholder guidance and support throughout the application process.
  • establishing regular reviews of listed products with ongoing stakeholder engagement.

We did

We carefully reviewed all suggestions, feedback, and recommendations. We are actively working to implement the proposed changes to streamline and modernise the application process for listing products in Part B.

Published responses

View submitted responses where consent has been given to publish the response.

Overview

In January 2022 we released Consultation Paper 2(a) – Modernisation of Part B of the PL, proposing improvements to Part B in alignment with broader changes to the PL.

Based on stakeholder feedback, we determined that further consultation was needed to clarify the proposals and address concerns. In December 2022, we engaged PricewaterhouseCoopers (PwC) to assist this process.

PwC ran workshops where stakeholders developed recommendations which were subsequently reflected in the final PwC report.

In May 2023, the department received PwC’s final report, which outlined 10 key recommendations and practical steps to support the proposed reforms to Part B of the PL.

 

Why your views matter

We are committed to developing informed and practical options for modernising Part B of the PL. The feedback from key stakeholders is essential in shaping reforms that enhance efficiency transparency and outcomes for all involved.

Audiences

  • Non-government organisations
  • State government agencies
  • Local governments
  • Health professionals
  • Biogicals

Interests

  • Hospitals
  • Health technology
  • Health insurance
  • Organ and tissue donation